Goldman Sachs Group Inc Mirum Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 395,008 shares of MIRM stock, worth $28.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
395,008
Previous 477,651
17.3%
Holding current value
$28.3 Million
Previous $21.5 Million
6.59%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$488 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$376 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$232 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$198 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$189 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...